Dr. David L. Bartlett

Carl Schmidt is a Surgical Oncologist and a General Surgeon in Morgantown, West Virginia. Dr. Schmidt is rated as a Distinguished provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Gallbladder Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Hepatectomy. Dr. Schmidt is currently accepting new patients.

Dr. Geller is a Professor of Surgery at the University of Pittsburgh School of Medicine, and Director of the UPMC Liver Cancer Center. As a hepatobiliary and liver transplant surgeon at the Starzl Transplant Institute, his clinical interests center on the evaluation and management of patients with liver cancers. He is focusing on novel and minimally invasive approaches for the treatment of liver cancer. He has particular operative expertise in performing laparoscopic liver resections and laparoscopic radiofrequency ablations of liver tumors. Dr. Geller is a member of many professional and scientific societies including the Society of Surgical Oncology, Society of University Surgeons, and the American Society of Transplant Surgeons. Dr. Geller is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Liver Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), Hepatectomy, and Hepato-Pancreato-Biliary Surgery.

Amer H. Zureikat, MD, is vice chair of surgery for surgical oncology in the Department of Surgery at UPMC, chief of Surgical Oncology at UPMC Hillman Cancer Center, and UPMC Chair of Clinical Surgery. He is the division chief for gastrointestinal surgical oncology in the Department of Surgery at UPMC and professor of surgery at the University of Pittsburgh School of Medicine. Dr. Zureikat specializes in cancers and diseases of the pancreas, stomach, liver and duodenum and is an expert in robotic pancreatic surgery. His clinical and academic interests include the multimodality treatment of pancreatic cancer, and comparative effectiveness of open and robotic approaches to gastrointestinal cancers in general and pancreatic cancer in particular. Dr. Zureikat is board-certified in general surgery. He received his medical degree from the Royal College of Surgeons in Dublin, Ireland, completed his general surgery residency at the University of Chicago Medical Center and his fellowship in surgical oncology at the University of Pittsburgh/UPMC. Dr. Zureikat is a member of the Society of University Surgeons (SUS), Society of Surgical Oncology (SSO), and the Americas Hepato-Pancreato-Biliary Association (AHPBA). In addition, he is a fellow of the American College of Surgeons (ACS). Dr. Zureikat is rated as an Elite provider by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Pancreatic Cancer, Pancreatic Islet Cell Tumor, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.